How to adjust metabolic rate (MR) in mice that differ in body mass and composition continues to lead to controversies. Here, the challenges that reside in the analysis of mouse MR are highlighted to spur consensus on the unequivocal use of regression-based analysis to maximize reliability and relevance of conclusions.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Threonic acid, an ascorbic acid metabolite, synergizes with intermittent fasting to ameliorate obesity
Experimental & Molecular Medicine Open Access 09 January 2026
-
PNPLA7 mediates Parkin-mitochondrial recruitment in adipose tissue for mitophagy and inhibits browning
Nature Communications Open Access 19 July 2025
-
Adenosine transmission from hypothalamic tanycytes to AGRP/NPY neurons regulates energy homeostasis
Experimental & Molecular Medicine Open Access 02 May 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Change history
08 October 2021
A Correction to this paper has been published: https://doi.org/10.1038/s42255-021-00485-6
References
Tschop, M. H. et al. Nat. Methods 9, 57–63 (2011).
Fernandez-Verdejo, R., Ravussin, E., Speakman, J. R. & Galgani, J. E. Nat. Methods 16, 797–799 (2019).
Packard, G. C. & Boardman, T. J. Comp. Biochem. Physiol. A 122, 37–44 (1999).
Speakman, J. R., Fletcher, Q. & Vaanholt, L. Dis. Model Mech. 6, 293–301 (2013).
Ravussin, E. & Bogardus, C. Am. J. Clin. Nutr. 49, 968–975 (1989).
Tanner, J. M. J. Appl. Physiol. 2, 1–15 (1949).
Weil, W. B. Jr Am. J. Clin. Nutr. 11, 249–252 (1962).
Packard, G. C. & Boardman, T. J. Physiol. Zool. 61, 1–9 (1988).
Mina, A. I. et al. Cell. Metab. 28, 656–666 (2018).
Kless, C., Rink, N., Rozman, J. & Klingenspor, M. Eur. J. Clin. Nutr. 71, 306–317 (2017).
Acknowledgements
This study was supported in part by funding from the German Research Foundation (DFG) TRR152 and TRR296, the European Research Council ERC AdG HypoFlam no. 695054 and the German Center for Diabetes Research (DZD e.V).
Author information
Authors and Affiliations
Contributions
T.D.M., M.K. and M.H.T. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
M.H.T. is a member of the scientific advisory board of ERX Pharmaceuticals, Cambridge, MA, USA. He was a member of the Research Cluster Advisory Panel (ReCAP) of the Novo Nordisk Foundation between 2017 and 2019. He attended a scientific advisory board meeting of the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, in 2016. He received funding for his research projects by Novo Nordisk (2016-2020) and Sanofi-Aventis (2012–2019). He was a consultant for Bionorica SE (2013–2017), Menarini Ricerche S.p.A. (2016) and Bayer Pharma AG Berlin (2016). As former director of the Helmholtz Diabetes Center and the Institute for Diabetes and Obesity at Helmholtz Zentrum München (2011–2018), and since 2018, as CEO of Helmholtz Zentrum München, M.H.T. has been responsible for collaborations with a multitude of companies and institutions worldwide. In this capacity, he discussed potential projects with and signed contracts for his institute(s) and the staff for research funding and/or collaborations with industry and academia worldwide, including but not limited to pharmaceutical corporations such as Boehringer Ingelheim, Eli Lilly, Novo Nordisk, MediGene, Arbormed, BioSyngen and others. In this role, he was/is further responsible for commercial technology transfer activities of his institute(s), including diabetes-related patent portfolios of Helmholtz Zentrum München such as WO/2016/188932 A2 and WO/2017/194499 A1. M.H.T. confirmed that to the best of his knowledge, none of the funding sources were involved in preparing this paper. T.D.M. receives research funding by Novo Nordisk, but these funds were unrelated to the work described herein. M.K. declares no competing interests.
Additional information
Peer review information Nature Metabolism thanks Joerg Heeren for their contribution to the peer review of this work.
Rights and permissions
About this article
Cite this article
Müller, T.D., Klingenspor, M. & Tschöp, M.H. Revisiting energy expenditure: how to correct mouse metabolic rate for body mass. Nat Metab 3, 1134–1136 (2021). https://doi.org/10.1038/s42255-021-00451-2
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s42255-021-00451-2
This article is cited by
-
Threonic acid, an ascorbic acid metabolite, synergizes with intermittent fasting to ameliorate obesity
Experimental & Molecular Medicine (2026)
-
E3 ligase FBXW7 suppresses brown fat expansion and browning of white fat
EMBO Reports (2025)
-
Myristoylated Eepd1 Enhances Lipolysis and Thermogenesis through PKA Activation to Combat Obesity
Nature Communications (2025)
-
Vestibular neurons link motion sickness, behavioural thermoregulation and metabolic balance in mice
Nature Metabolism (2025)
-
Adenosine transmission from hypothalamic tanycytes to AGRP/NPY neurons regulates energy homeostasis
Experimental & Molecular Medicine (2025)